{"product_id":"treatment-of-inflammatory-bowel-disease-with-biologics-clinical","title":"Treatment of Inflammatory Bowel Disease with Biologics - Clinical","description":"\u003cp\u003eIn this review of Treatment of Inflammatory Bowel Disease with Biologics, the authors present a concise, clinically focused resource for practitioners managing Crohn's disease and ulcerative colitis. The book's single biggest reason to buy is its practical synthesis of how to use biologic therapies safely and effectively, covering new data, novel agents, and biosimilars. Written by experts, it reads like a targeted reference for busy clinicians who need clear guidance on optimizing efficacy, recognizing complications, and choosing between available biologic options.\u003c\/p\u003e\n\u003ch2\u003eKey Features\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcise clinical guidance:\u003c\/strong\u003e The text distills complex trial data into actionable recommendations for treating Crohn's disease and ulcerative colitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocus on safety:\u003c\/strong\u003e Chapters explain how to monitor for and manage complications that may arise from biologic therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoverage of novel agents:\u003c\/strong\u003e The book reviews new biologics and emerging therapies so clinicians can stay current with an expanding field.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiosimilar discussion:\u003c\/strong\u003e Practical information on biosimilars helps prescribers understand interchangeability and cost-conscious prescribing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAuthored by experts:\u003c\/strong\u003e Written by clinicians experienced in inflammatory bowel disease, providing an informed and practice-oriented perspective.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho It's For\u003c\/h2\u003e\n\u003cp\u003eThis book is best suited to practicing gastroenterologists, IBD fellows, and allied health professionals who require a focused, clinically useful guide to biologic therapy. It works well as a quick reference for inpatient consults or outpatient treatment planning when decisions about induction, maintenance, safety monitoring, and handling complications are needed.\u003c\/p\u003e\n\u003cp\u003eThose seeking basic introductory material for nonmedical audiences or comprehensive, textbook-length pathophysiology may prefer a more general or expansive reference. The book's strength is clinical application rather than broad immunology or patient-facing education.\u003c\/p\u003e\n\u003ch2\u003ePros \u0026amp; Cons\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePros\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eConcise, practice-focused summaries that facilitate clinical decision making.\u003c\/li\u003e\n\u003cli\u003eClear guidance on safety and complication management relevant to everyday care.\u003c\/li\u003e\n\u003cli\u003eInclusion of new biologics and biosimilars helps clinicians navigate current options.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCons\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNot intended as a comprehensive textbook on basic science or broad epidemiology, so readers wanting exhaustive background may need supplemental texts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eTitle\u003c\/td\u003e\n\u003ctd\u003eTreatment of Inflammatory Bowel Disease with Biologics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuthors\u003c\/td\u003e\n\u003ctd\u003eAdam S. Cheifetz, Joseph D. Feuerstein\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubject\u003c\/td\u003e\n\u003ctd\u003eUse of biologics for Crohn's disease and ulcerative colitis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFocus\u003c\/td\u003e\n\u003ctd\u003eClinical application, safety, novel biologics and biosimilars\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntended audience\u003c\/td\u003e\n\u003ctd\u003eGastroenterologists, fellows, allied health professionals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003eOur Verdict\u003c\/h2\u003e\n\u003cp\u003eTreatment of Inflammatory Bowel Disease with Biologics is a high-value, concise clinical reference for clinicians managing IBD who need practical guidance on biologic selection, monitoring, and complication management. Its focused approach on new agents and biosimilars makes it especially useful for specialists and trainees seeking up-to-date, actionable information.\u003c\/p\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this book cover biosimilars?\u003c\/strong\u003e\u003cbr\u003eYes. The text explicitly discusses biosimilars and their role alongside novel biologics to help clinicians make informed prescribing decisions.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs it suitable for trainees?\u003c\/strong\u003e\u003cbr\u003eYes. Fellows and trainees in gastroenterology will find the concise, practice-oriented guidance helpful for clinical learning and decision making.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes it include safety and complication management?\u003c\/strong\u003e\u003cbr\u003eYes. The book focuses on recognizing, understanding, and treating complications that may arise from biologic therapy.\u003c\/p\u003e","brand":"Adam S. Cheifetz, Joseph D. Feuerstein","offers":[{"title":"Default Title","offer_id":48252615622875,"sku":"3319868233","price":109.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/1043\/1707\/files\/61oCV3z9PwL._SL1255.jpg?v=1778333026","url":"https:\/\/gearmusthave.com\/products\/treatment-of-inflammatory-bowel-disease-with-biologics-clinical","provider":"GearMustHave","version":"1.0","type":"link"}